NDC 86032-021 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86032-021
- Package NDCs from labels
- 86032-021-01
- Manufacturer
- Evereen Shanghai Biotechnology Ltd.
- Effective date
- 2023-02-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir | Evereen Shanghai Biotechnology Ltd. | 2023-02-08 | BULK INGREDIENT - ANIMAL DRUG |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| acyclovir | ACYCLOVIR | A-S Medication Solutions | c40a57b9-4cf1-4a69-abf3-eb99a7fcda00 | 2023-04-16 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | 34a38cdf-04e8-4006-a9f5-4a0831117d61 | 2023-02-06 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Modavar Pharmaceuticals LLC | 8de9c4f3-b800-4419-a063-8b62a0cba0fa | 2022-12-29 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Quinn Pharmaceuticals | 9ad711e4-003d-4b58-8177-32928bc42aa9 | 2022-12-20 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | PharmPak, Inc. | d824fc07-9f03-4cb2-9bf8-ff7cc2955255 | 2022-10-09 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | PharmPak, Inc. | 8fb01f23-e2bd-6850-e053-2995a90a7cc5 | 2022-10-09 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Viona Pharmaceuticals Inc | 12df1991-fb1c-45df-acf3-706b1e8ecfc3 | 2022-10-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Camber Pharmaceuticals, Inc. | 2ca1395f-96b4-4543-8eed-bd07c62bbc7c | 2022-09-12 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | e8056ec6-d2dc-48af-8550-82726af1c5c5 | 2022-08-01 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | 9e5b3a11-9c4b-4998-8a18-3046af1314ab | 2022-06-01 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | 33630a35-346e-43b6-9286-89e28ac0094a | 2022-06-01 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | c55bde35-a202-4c25-b545-e5d5e95c1175 | 2022-04-01 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Proficient Rx LP | 32aa3f42-23a1-4867-8228-e6e76cf9f135 | 2022-02-01 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Solco Healthcare US, LLC | a1d7b8ec-309d-447e-ae05-b9e89cc29948 | 2021-11-15 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Macleods Pharmaceuticals Limited | d42fce5a-9ea3-4058-a3ba-4c18a6024160 | 2021-08-24 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Amneal Pharmaceuticals LLC | 9167ea4a-959d-402c-96b4-619395821c01 | 2021-07-23 | Warnings, Adverse reactions | X4HES1O11F |
| Zovirax | ACYCLOVIR | Bausch Health US, LLC | 125dbe4e-94ba-45bd-a714-f9c4b8e8b5c2 | 2021-02-01 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Proficient Rx LP | 3da54b2d-a206-4ff5-8cc2-90762c4fd70d | 2021-01-01 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Proficient Rx LP | 4c5a75fa-73db-4f48-895f-de1635d33f49 | 2021-01-01 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Proficient Rx LP | 8d7994a6-5bd2-494d-89c1-b03755d4f2c3 | 2020-12-01 | Warnings, Adverse reactions | X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.